JPMorgan Chase & Co. Acquires 903,841 Shares of Sabra Healthcare REIT, Inc. $SBRA

JPMorgan Chase & Co. boosted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 33.7% in the third quarter, HoldingsChannel.com reports. The firm owned 3,589,253 shares of the real estate investment trust’s stock after buying an additional 903,841 shares during the period. JPMorgan Chase & Co.’s holdings in Sabra Healthcare REIT were worth $66,904,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Founders Capital Management acquired a new position in Sabra Healthcare REIT during the 3rd quarter worth about $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Larson Financial Group LLC increased its stake in shares of Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the period. Covestor Ltd increased its stake in shares of Sabra Healthcare REIT by 23,720.0% in the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in shares of Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 1,536 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on SBRA. Jefferies Financial Group reaffirmed a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Cantor Fitzgerald increased their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. Citizens Jmp raised their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Wells Fargo & Company boosted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Finally, Truist Financial upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $21.90.

Sabra Healthcare REIT Stock Performance

SBRA stock opened at $20.24 on Friday. The firm has a market cap of $5.10 billion, a PE ratio of 31.63, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The stock has a 50-day moving average price of $19.74 and a 200-day moving average price of $19.05. Sabra Healthcare REIT, Inc. has a 1-year low of $15.75 and a 1-year high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same quarter in the previous year, the company earned $0.36 EPS. The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.